High Caffeine Levels Found in Oregon: A Statewide Investigation into Energy Drinks, Cold Brews, and Regulatory Gaps

Alarming Caffeine Concentrations Detected Across Oregon Retail Channels

In late 2023, Oregon Health Authority (OHA) investigators confirmed unusually high caffeine levels in 17 out of 42 tested beverages sold across the state—spanning energy drinks, cold brew coffees, sparkling teas, and pre-workout supplements. Lab analysis conducted by the Oregon State Public Health Laboratory found caffeine concentrations exceeding 300 mg per 12-ounce serving in six products, with one Portland-brewed cold brew concentrate registering 582 mg per 8-ounce serving—nearly six times the caffeine in a standard 8-oz brewed coffee (95 mg). These findings triggered urgent advisories from OHA’s Food Safety Section and prompted renewed scrutiny of labeling practices, manufacturing oversight, and consumer education efforts, particularly among adolescents and young adults in urban centers like Portland and Eugene.

The Data Behind the Alert: Lab Results and Geographic Hotspots

OHA’s surveillance program, launched in response to a 22% year-over-year increase in caffeine-related emergency department visits among Oregonians aged 12–25 (2022–2023), collected samples from 31 retail locations—including grocery chains (Fred Meyer, New Seasons Market), independent cafes (Stumptown Coffee Roasters, Coava Coffee), and convenience stores (7-Eleven, QuickTrip). All samples were analyzed using high-performance liquid chromatography (HPLC) at the state lab in Hillsboro, with detection limits of ±0.5 mg per serving.

Top Five Highest-Caffeine Beverages Identified

• RevvUp Cold Brew Concentrate (Portland, OR): 582 mg caffeine per 8 oz (72.75 mg/oz)
• NeuroGasm Ultra Shot (distributed by Vitality Labs, Salem-based distributor): 350 mg per 2 oz serving (175 mg/oz)
• Stumptown Nitro Cold Brew (16 oz can, batch #SNCB-2023-089): 310 mg per 16 oz (19.4 mg/oz)
• Runa Clean Energy Sparkling Tea (Lime Mint, 12 oz can): 180 mg per 12 oz (15 mg/oz)
• Ghost Legend Pre-Workout (sold at GNC stores in Beaverton and Medford): 300 mg per scoop (5g), when mixed with water—though label states "up to 250 mg"; actual assay revealed 302 mg ±2.3 mg

Notably, all five products are manufactured or distributed within Oregon, with four produced in facilities located in Multnomah or Lane counties. The RevvUp concentrate—brewed in a shared commercial kitchen in NE Portland—was found to contain no warning label regarding caffeine content beyond the generic "Contains Caffeine" statement mandated under federal law. Its packaging lists only "organic coffee beans, filtered water," omitting any quantification despite its concentration surpassing the FDA’s recommended single-dose limit of 400 mg for healthy adults.

Federal Standards vs. Oregon Reality: A Regulatory Mismatch

The U.S. Food and Drug Administration does not set mandatory upper limits for caffeine in food or beverages, except for colas (which must not exceed 71 mg per 12 oz under 21 CFR §101.4). Energy drinks and coffee-based beverages operate under a voluntary framework: manufacturers may disclose caffeine content but are not required to do so unless making a nutrient content claim (e.g., "high in caffeine"). This regulatory gap has allowed significant variability—and, as Oregon’s data show, potentially hazardous concentrations—to persist unchecked.

Oregon’s own food code, adopted from the 2022 FDA Food Code, contains no provisions governing caffeine dosage or labeling thresholds. In contrast, Canada requires all prepackaged foods containing added caffeine to declare the amount per serving on the Nutrition Facts table. The European Food Safety Authority (EFSA) recommends a maximum acute intake of 200 mg per single dose and 400 mg daily for adults—but these remain non-binding guidelines.

How Oregon Compares Nationally

A comparative review of 2023 caffeine surveillance data from 12 states shows Oregon ranked third-highest in median caffeine concentration per serving among cold brew products (142 mg/12 oz), behind only Colorado (156 mg) and Vermont (149 mg). However, Oregon led all states in prevalence of unquantified caffeine labeling: 68% of tested cold brews and energy shots lacked numeric caffeine declarations, compared to a national average of 41%. This discrepancy is partly attributable to Oregon’s exemption from certain federal nutrition labeling requirements for small-batch producers—those with fewer than $500,000 in annual sales—as codified in ORS 616.225(3).

Public Health Impacts: ER Visits, Sleep Disruption, and Youth Exposure

OHA’s Emergency Department Surveillance System documented 147 caffeine-related visits across Oregon hospitals in 2023—a 22% rise from 120 in 2022. Of those, 41% involved patients under age 20. The most common presenting symptoms included tachycardia (heart rate >110 bpm), acute anxiety, gastrointestinal distress, and insomnia lasting more than 48 hours. At OHSU Doernbecher Children’s Hospital in Portland, pediatric toxicology logs show a 37% increase in caffeine overdose consultations since 2021, with cases linked directly to consumption of RevvUp concentrate and NeuroGasm Ultra Shot.

Dr. Lena Cho, Medical Director of Toxicology at OHSU, emphasized physiological vulnerability: "A 14-year-old weighing 45 kg who consumes one 8-oz serving of RevvUp receives approximately 12.9 mg/kg of caffeine—well above the 3–5 mg/kg threshold associated with clinically significant adrenergic effects. That’s equivalent to drinking nearly seven 8-oz cups of drip coffee in rapid succession." She further noted that adolescent brains exhibit heightened sensitivity to caffeine-induced dopamine modulation, correlating with increased risk of sleep architecture disruption and attentional deficits observed in longitudinal school-based surveys in Eugene School District 4J.

Sleep and Academic Performance Correlations

A 2023 University of Oregon study tracked 842 undergraduate students across Eugene and Portland campuses over one academic term. Participants consuming ≥200 mg caffeine after 2 p.m. showed:

1. 43% longer sleep onset latency (mean 41.2 vs. 28.7 minutes)
2. 22% reduction in slow-wave sleep duration
3. 1.4-point average GPA decline (on a 4.0 scale) compared to low-caffeine peers with matched baseline GPAs
4. 3.6x higher incidence of self-reported 'brain fog' during morning classes

These findings align with clinical sleep studies conducted at Oregon Health & Science University’s Sleep Disorders Center, where polysomnography confirmed reduced REM density and elevated nocturnal cortisol in habitual high-caffeine consumers—even when intake occurred before noon.

Industry Response: Transparency Efforts and Voluntary Reforms

In March 2024, the Oregon Specialty Coffee Association (OSCA) announced a new voluntary labeling initiative requiring member roasters to publish caffeine content per standard serving on packaging and digital menus by July 1, 2024. As of May 2024, 41 of 63 OSCA members—including Coava, Heart Coffee Roasters, and Water Avenue Coffee—have committed. However, non-member entities such as RevvUp and Vitality Labs have declined to participate, citing proprietary formulation concerns.

Meanwhile, major retailers are adjusting shelf protocols. Fred Meyer implemented a policy in April 2024 restricting placement of beverages with >200 mg caffeine per serving to behind-the-counter sections in all 28 Oregon locations. New Seasons Market introduced QR-code-linked digital labels providing full nutritional breakdowns—including caffeine—on 100% of its private-label cold brews and energy tonics.

Consumer Advocacy and Legislative Momentum

Coffee Strong, a Portland-based nonprofit focused on beverage safety education, launched the "Know Your Dose" campaign in February 2024, distributing over 12,000 bilingual (English/Spanish) pocket guides listing caffeine equivalents: e.g., "1 shot of RevvUp = 6 cups of Starbucks Pike Place." The group also filed a petition with the Oregon Legislature urging HB 4092, which would require numeric caffeine disclosure on all packaged beverages sold in Oregon if they contain >50 mg per serving. As of June 2024, the bill has passed the House Health Care Committee and awaits full chamber vote.

What Consumers Can Do: Practical Guidance and Risk Mitigation

Health professionals and regulators stress that caffeine is not inherently dangerous—but dose, timing, and individual physiology determine safety. Oregon’s findings underscore the need for proactive consumer strategies, especially given inconsistent labeling and variable preparation methods.

For example, cold brew concentrate is often diluted at home, yet many consumers use it undiluted or mix it with additional stimulants (e.g., matcha powder or guarana extract), unknowingly compounding exposure. Similarly, energy shots labeled "2 oz" may be consumed in full despite containing doses intended for split administration.

OHA’s Consumer Protection Division recommends the following evidence-based actions:

• Check the Nutrition Facts panel—or ingredient list—for terms like "caffeine anhydrous," "green tea extract," "guarana," or "yerba mate," all of which contribute bioactive caffeine
• Use standardized conversion: 1 mg caffeine per kg body weight ≈ safe single dose for adolescents; 2.5–3 mg/kg for adults
• Avoid consuming caffeine within 8 hours of bedtime—even if you feel tolerant—to preserve circadian alignment
• When ordering custom cold brew, ask for the base concentration (e.g., "Is this 1:4 or 1:8 ratio?") and request dilution guidance
• Track intake using free tools like the NIH’s Caffeine Calculator or MyFitnessPal’s verified caffeine database

A Statewide Table of Tested Beverages and Caffeine Metrics

Looking Ahead: Research Gaps and Policy Pathways

Despite Oregon’s robust surveillance, critical knowledge gaps remain. No state-funded study has yet examined caffeine metabolism variability among Oregon’s diverse populations—including Indigenous communities, Latinx farmworkers in the Willamette Valley, or elderly residents in coastal retirement communities. Genetic polymorphisms in CYP1A2—the primary liver enzyme responsible for caffeine clearance—can cause up to 8-fold differences in half-life, meaning two individuals consuming identical doses may experience markedly different physiological responses.

Additionally, emerging product categories pose new challenges. Ready-to-drink mushroom adaptogen blends (e.g., Four Sigmatic’s Lion’s Mane Cold Brew) now appear alongside traditional cold brews in Oregon markets—yet their caffeine content is frequently obscured by claims of "calm energy" or "non-jittery focus." Lab assays of three such products purchased in Bend revealed caffeine levels ranging from 98 to 162 mg per 11 oz serving—despite zero mention of caffeine on front-of-pack labeling.

OHA’s 2024–2026 Strategic Plan includes allocating $285,000 toward expanded caffeine testing capacity and community-based participatory research in partnership with tribal health departments and the Oregon Farmworker Housing Coalition. Meanwhile, the Oregon Board of Pharmacy is reviewing whether to classify ultra-concentrated caffeine products (>200 mg/serving) as "restricted access" items—similar to pseudoephedrine—requiring age verification and purchase logs.

As Dr. Aris Thorne, OHA’s Deputy Director for Environmental Health, stated in testimony before the Senate Health Committee in May 2024: "We’re not regulating coffee. We’re regulating transparency, consistency, and preventable harm. When a teenager buys what looks like a flavored sparkling water and ingests the caffeine equivalent of four espressos, that’s not choice—it’s information failure." Oregon’s experience offers a granular case study in how localized data collection, cross-sector collaboration, and responsive policymaking can recalibrate consumer safeguards without stifling innovation or tradition.

This investigation reaffirms that caffeine safety hinges less on prohibition than on precision: precise measurement, precise labeling, and precise communication. With over 21 million servings of caffeinated beverages consumed weekly in Oregon alone—according to NielsenIQ retail scan data—the state’s next chapter in beverage regulation may well set precedent for other jurisdictions navigating the same complex terrain between public health, economic vitality, and cultural practice.

For updated test results, retailer advisories, and printable caffeine equivalency charts, visit oha.oregon.gov/foodsafety/caffeine. Oregonians experiencing acute caffeine-related symptoms should call the Oregon Poison Center at 1-800-222-1222—available 24/7 and staffed by certified specialists.

Consumers outside Oregon can replicate aspects of this investigation by requesting laboratory assay reports from local health departments or utilizing third-party verification services such as ConsumerLab.com, which tested 37 cold brew products in 2023 and found 29% exceeded declared caffeine levels by ≥15%.

It bears noting that not all high-caffeine products pose equal risk. Duration of exposure matters: slow-release formulations (e.g., time-release capsules or cellulose-encapsulated powders) produce lower peak plasma concentrations than rapidly absorbed liquids. Likewise, co-ingestion of L-theanine—as found naturally in green tea or added to some functional beverages—has been shown in randomized trials to attenuate caffeine-induced jitteriness without reducing alertness.

Finally, Oregon’s coffee culture remains deeply rooted in quality, craft, and community. What’s shifting is not the reverence for the bean—but the expectation that respect extends to clarity about its potency. From the mist-shrouded farms of the Columbia River Gorge to the espresso bars of Southeast Hawthorne, Oregonians are proving that vigilance and vitality need not be mutually exclusive.

The RevvUp concentrate incident did not spark a ban—it sparked a dialogue. And in that dialogue, measured by milligrams and moderated by science, lies Oregon’s most potent ingredient yet: accountability.